Varda raises $250 million at $1.6 billion valuation to scale orbital drug manufacturing
The round brings Varda's total funding to $598 million as it expands microgravity missions for pharmaceutical production and Pentagon research payloads.
- El Segundo-based Varda Space Industries raised $250 million in a Series D round this month, bringing total capital raised to $598 million since its 2021 founding.
- Microgravity enables unique crystallization of active pharmaceutical ingredients impossible to replicate on Earth, creating potential new drug formulations that Varda aims to bring to market.
- Varda has completed six successful missions since 2023 and plans to launch two capsules next Thursday on a SpaceX Falcon 9 rocket carrying hypersonic research payloads for the Pentagon and commercial customers.
- "This round gives us the resources to increase our cadence, deepen our pharmaceutical partnerships, get closer to delivering the first medicine made in space," said co-founder and president Delian Asparouhov.
- Varda aims to inject a microgravity-manufactured formulation into a human patient by 2030 while competing with SpaceX's Starfall and Inversion Space in the emerging orbital manufacturing market.
11 Articles
11 Articles
Channel News Asia
Varda raises $250 million at $1.6 billion valuation to scale orbital drug manufacturing
WASHINGTON, Sept 30 : In-space manufacturing startup Varda Space has raised $250 million in a Series D round at a $1.6 billion valuation, the company told Reuters, as it ramps up missions to produce pharmaceuticals in microgravity.El Segundo-based Varda is one of a handful of US companies building a fleet of
This El Segundo Startup Wants to Manufacture Medicine in Space
🔦 SpotlightHappy Friday, Los Angeles.The next major pharmaceutical factory may not be built in Boston, New Jersey or Switzerland.It may be orbiting hundreds of miles above Earth.El Segundo-based Varda Space Industries raised a $251M Series D this week to advance an ambitious idea: manufacturing medicines in microgravity and returning them to patients on Earth.The round was led by Lux Capital and Natural Capital, with participation from Founders…
Startup Varda Space has raised $250 million in a Series D funding round, valuing it at $1.6 billion, as it ramps up its missions… Production of drugs in space attracts investor interest - ΙΝΑΦΤΕΜΟΠΟΡΙΚΙ
Varda Space Industries Raises $251 Million to Scale In-Space Pharmaceutical Processing
Varda Space Industries has raised $251 million in a Series D funding round to scale its space-based pharmaceutical processing operations and increase the cadence of its orbital missions. The funding brings the company’s total capital raised to $598 million as Varda moves toward producing pharmaceuticals in microgravity for use on Earth.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
